世界のオメプラゾール市場予測 2021年-2026年

【英語タイトル】Global Omeprazole Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9607)・商品コード:LPI21MY9607
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:165
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「オメプラゾールの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カプセル、錠剤、注射など、用途別には、子供、大人などにセグメント区分してまとめました。オメプラゾールのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・オメプラゾールの世界市場概要(サマリー)
・オメプラゾールの企業別販売量・売上
・オメプラゾールの企業別市場シェア
・オメプラゾールの世界市場規模 2016年-2021年:種類別(カプセル、錠剤、注射)
・オメプラゾールの世界市場規模 2016年-2021年:用途別(子供、大人)
・オメプラゾールの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・オメプラゾールのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・オメプラゾールのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・オメプラゾールの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・オメプラゾール市場の成長要因・課題・動向
・オメプラゾールの世界市場予測 2021年-2026年
・オメプラゾールの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・オメプラゾールのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・オメプラゾールのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・オメプラゾールの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・オメプラゾールの世界市場予測:種類別(カプセル、錠剤、注射)
・オメプラゾールの世界市場予測:用途別(子供、大人)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Omeprazole will have significant change from previous year. By the most conservative estimates of global Omeprazole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2346.4 million in 2019. Over the next five years the Omeprazole market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 2646.9 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Omeprazole market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Capsule
Tablet
Injection

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Children
Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AstraZeneca AB
Sandoz
Actavis
Teva
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi, Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Omeprazole Consumption 2016-2026
2.1.2 Omeprazole Consumption CAGR by Region
2.2 Omeprazole Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.2.3 Injection
2.3 Omeprazole Sales by Type
2.3.1 Global Omeprazole Sales Market Share by Type (2016-2021)
2.3.2 Global Omeprazole Revenue and Market Share by Type (2016-2021)
2.3.3 Global Omeprazole Sale Price by Type (2016-2021)
2.4 Omeprazole Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Omeprazole Sales by Application
2.5.1 Global Omeprazole Sale Market Share by Application (2016-2021)
2.5.2 Global Omeprazole Revenue and Market Share by Application (2016-2021)
2.5.3 Global Omeprazole Sale Price by Application (2016-2021)

3 Global Omeprazole by Company
3.1 Global Omeprazole Sales Market Share by Company
3.1.1 Global Omeprazole Sales by Company (2019-2021)
3.1.2 Global Omeprazole Sales Market Share by Company (2019-2021)
3.2 Global Omeprazole Revenue Market Share by Company
3.2.1 Global Omeprazole Revenue by Company (2019-2021)
3.2.2 Global Omeprazole Revenue Market Share by Company (2019-2021)
3.3 Global Omeprazole Sale Price by Company
3.4 Global Manufacturers Omeprazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Omeprazole Product Location Distribution
3.4.2 Players Omeprazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Omeprazole by Region
4.1 Global Omeprazole by Region
4.1.1 Global Omeprazole Sales by Region
4.1.2 Global Omeprazole Revenue by Region
4.2 Americas Omeprazole Sales Growth
4.3 APAC Omeprazole Sales Growth
4.4 Europe Omeprazole Sales Growth
4.5 Middle East & Africa Omeprazole Sales Growth

5 Americas
5.1 Americas Omeprazole Sales by Country
5.1.1 Americas Omeprazole Sales by Country (2016-2021)
5.1.2 Americas Omeprazole Revenue by Country (2016-2021)
5.2 Americas Omeprazole Sales by Type
5.3 Americas Omeprazole Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Omeprazole Sales by Region
6.1.1 APAC Omeprazole Sales by Region (2016-2021)
6.1.2 APAC Omeprazole Revenue by Region (2016-2021)
6.2 APAC Omeprazole Sales by Type
6.3 APAC Omeprazole Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Omeprazole by Country
7.1.1 Europe Omeprazole Sales by Country (2016-2021)
7.1.2 Europe Omeprazole Revenue by Country (2016-2021)
7.2 Europe Omeprazole Sales by Type
7.3 Europe Omeprazole Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Omeprazole by Country
8.1.1 Middle East & Africa Omeprazole Sales by Country (2016-2021)
8.1.2 Middle East & Africa Omeprazole Revenue by Country (2016-2021)
8.2 Middle East & Africa Omeprazole Sales by Type
8.3 Middle East & Africa Omeprazole Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Omeprazole Distributors
10.3 Omeprazole Customer

11 Global Omeprazole Market Forecast
11.1 Global Omeprazole Forecast by Region
11.1.1 Global Omeprazole Forecast by Regions (2021-2026)
11.2.2 Global Omeprazole Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Omeprazole Forecast by Type
11.7 Global Omeprazole Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca AB
12.1.1 AstraZeneca AB AstraZeneca AB Company Information
12.1.2 AstraZeneca AB Omeprazole Product Offered
12.1.3 AstraZeneca AB Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AstraZeneca AB Main Business Overview
12.1.5 AstraZeneca AB Latest Developments
12.2 Sandoz
12.2.1 Sandoz Company Information
12.2.2 Sandoz Omeprazole Product Offered
12.2.3 Sandoz Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sandoz Main Business Overview
12.2.5 Sandoz Latest Developments
12.3 Actavis
12.3.1 Actavis Company Information
12.3.2 Actavis Omeprazole Product Offered
12.3.3 Actavis Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Actavis Main Business Overview
12.3.5 Actavis Latest Developments
12.4 Teva
12.4.1 Teva Company Information
12.4.2 Teva Omeprazole Product Offered
12.4.3 Teva Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Teva Main Business Overview
12.4.5 Teva Latest Developments
12.5 Mylan
12.5.1 Mylan Company Information
12.5.2 Mylan Omeprazole Product Offered
12.5.3 Mylan Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Mylan Main Business Overview
12.5.5 Mylan Latest Developments
12.6 KernPharm
12.6.1 KernPharm Company Information
12.6.2 KernPharm Omeprazole Product Offered
12.6.3 KernPharm Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 KernPharm Main Business Overview
12.6.5 KernPharm Latest Developments
12.7 Garmish Pharmaceuticals
12.7.1 Garmish Pharmaceuticals Company Information
12.7.2 Garmish Pharmaceuticals Omeprazole Product Offered
12.7.3 Garmish Pharmaceuticals Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Garmish Pharmaceuticals Main Business Overview
12.7.5 Garmish Pharmaceuticals Latest Developments
12.8 Sanofi, Mepha
12.8.1 Sanofi, Mepha Company Information
12.8.2 Sanofi, Mepha Omeprazole Product Offered
12.8.3 Sanofi, Mepha Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sanofi, Mepha Main Business Overview
12.8.5 Sanofi, Mepha Latest Developments
12.9 Saval Pharmaceutical
12.9.1 Saval Pharmaceutical Company Information
12.9.2 Saval Pharmaceutical Omeprazole Product Offered
12.9.3 Saval Pharmaceutical Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Saval Pharmaceutical Main Business Overview
12.9.5 Saval Pharmaceutical Latest Developments
12.10 Stada
12.10.1 Stada Company Information
12.10.2 Stada Omeprazole Product Offered
12.10.3 Stada Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Stada Main Business Overview
12.10.5 Stada Latest Developments
12.11 Blaskov
12.11.1 Blaskov Company Information
12.11.2 Blaskov Omeprazole Product Offered
12.11.3 Blaskov Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Blaskov Main Business Overview
12.11.5 Blaskov Latest Developments
12.12 CQ Lummy
12.12.1 CQ Lummy Company Information
12.12.2 CQ Lummy Omeprazole Product Offered
12.12.3 CQ Lummy Omeprazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 CQ Lummy Main Business Overview
12.12.5 CQ Lummy Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Omeprazole Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Capsule
Table 3. Major Players of Tablet
Table 4. Major Players of Injection
Table 5. Global Omeprazole Sales by Type (2016-2021) & (K MT)
Table 6. Global Omeprazole Sales Market Share by Type (2016-2021)
Table 7. Global Omeprazole Revenue by Type (2016-2021) & ($ million)
Table 8. Global Omeprazole Revenue Market Share by Type (2016-2021)
Table 9. Global Omeprazole Sale Price by Type (2016-2021)
Table 10. Global Omeprazole Sales by Application (2016-2021) & (K MT)
Table 11. Global Omeprazole Sales Market Share by Application (2016-2021)
Table 12. Global Omeprazole Value by Application (2016-2021)
Table 13. Global Omeprazole Revenue Market Share by Application (2016-2021)
Table 14. Global Omeprazole Sale Price by Application (2016-2021)
Table 15. Global Omeprazole Sales by Company (2019-2021) & (K MT)
Table 16. Global Omeprazole Sales Market Share by Company (2019-2021)
Table 17. Global Omeprazole Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Omeprazole Revenue Market Share by Company (2019-2021)
Table 19. Global Omeprazole Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Omeprazole Producing Area Distribution and Sales Area
Table 21. Players Omeprazole Products Offered
Table 22. Omeprazole Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Omeprazole Sales by Region (2016-2021) (K MT)
Table 26. Global Omeprazole Sales Market Share by Region (2016-2021)
Table 27. Global Omeprazole Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Omeprazole Revenue Market Share by Region (2016-2021)
Table 29. Americas Omeprazole Sales by Country (2016-2021) & (K MT)
Table 30. Americas Omeprazole Sales Market Share by Country (2016-2021)
Table 31. Americas Omeprazole Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Omeprazole Revenue Market Share by Country (2016-2021)
Table 33. Americas Omeprazole Sales by Type (2016-2021) & (K MT)
Table 34. Americas Omeprazole Sales Market Share by Type (2016-2021)
Table 35. Americas Omeprazole Sales by Application (2016-2021) & (K MT)
Table 36. Americas Omeprazole Sales Market Share by Application (2016-2021)
Table 37. APAC Omeprazole Sales by Region (2016-2021) & (K MT)
Table 38. APAC Omeprazole Sales Market Share by Region (2016-2021)
Table 39. APAC Omeprazole Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Omeprazole Revenue Market Share by Region (2016-2021)
Table 41. APAC Omeprazole Sales by Type (2016-2021) & (K MT)
Table 42. APAC Omeprazole Sales Market Share by Type (2016-2021)
Table 43. APAC Omeprazole Sales by Application (2016-2021) & (K MT)
Table 44. APAC Omeprazole Sales Market Share by Application (2016-2021)
Table 45. Europe Omeprazole Sales by Country (2016-2021) & (K MT)
Table 46. Europe Omeprazole Sales Market Share by Country (2016-2021)
Table 47. Europe Omeprazole Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Omeprazole Revenue Market Share by Country (2016-2021)
Table 49. Europe Omeprazole Sales by Type (2016-2021) & (K MT)
Table 50. Europe Omeprazole Sales Market Share by Type (2016-2021)
Table 51. Europe Omeprazole Sales by Application (2016-2021) & (K MT)
Table 52. Europe Omeprazole Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Omeprazole Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Omeprazole Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Omeprazole Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Omeprazole Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Omeprazole Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Omeprazole Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Omeprazole Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Omeprazole Sales Market Share by Application (2016-2021)
Table 61. Global Omeprazole Sales Forecast by Type (2021-2026) & (K MT)
Table 62. Global Omeprazole Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Omeprazole Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Omeprazole Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Omeprazole Sales Forecast by Application (2021-2026) & (K MT)
Table 66. Global Omeprazole Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Omeprazole Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Omeprazole Revenue Market Share Forecast by Application (2021-2026)
Table 69. AstraZeneca AB Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 70. AstraZeneca AB Omeprazole Product Offered
Table 71. AstraZeneca AB Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 72. AstraZeneca AB Main Business
Table 73. AstraZeneca AB Latest Developments
Table 74. Sandoz Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 75. Sandoz Omeprazole Product Offered
Table 76. Sandoz Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 77. Sandoz Main Business
Table 78. Sandoz Latest Developments
Table 79. Actavis Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 80. Actavis Omeprazole Product Offered
Table 81. Actavis Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 82. Actavis Main Business
Table 83. Actavis Latest Developments
Table 84. Teva Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva Omeprazole Product Offered
Table 86. Teva Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. Mylan Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Omeprazole Product Offered
Table 91. Mylan Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. KernPharm Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 95. KernPharm Omeprazole Product Offered
Table 96. KernPharm Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. KernPharm Main Business
Table 98. KernPharm Latest Developments
Table 99. Garmish Pharmaceuticals Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 100. Garmish Pharmaceuticals Omeprazole Product Offered
Table 101. Garmish Pharmaceuticals Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 102. Garmish Pharmaceuticals Main Business
Table 103. Garmish Pharmaceuticals Latest Developments
Table 104. Sanofi, Mepha Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi, Mepha Omeprazole Product Offered
Table 106. Sanofi, Mepha Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 107. Sanofi, Mepha Main Business
Table 108. Sanofi, Mepha Latest Developments
Table 109. Saval Pharmaceutical Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 110. Saval Pharmaceutical Omeprazole Product Offered
Table 111. Saval Pharmaceutical Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 112. Saval Pharmaceutical Main Business
Table 113. Saval Pharmaceutical Latest Developments
Table 114. Stada Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 115. Stada Omeprazole Product Offered
Table 116. Stada Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 117. Stada Main Business
Table 118. Stada Latest Developments
Table 119. Blaskov Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 120. Blaskov Omeprazole Product Offered
Table 121. Blaskov Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 122. Blaskov Main Business
Table 123. Blaskov Latest Developments
Table 124. CQ Lummy Basic Information, Omeprazole Manufacturing Base, Sales Area and Its Competitors
Table 125. CQ Lummy Omeprazole Product Offered
Table 126. CQ Lummy Omeprazole Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 127. CQ Lummy Main Business
Table 128. CQ Lummy Latest Developments
List of Figures
Figure 1. Picture of Omeprazole
Figure 2. Omeprazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Omeprazole Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Omeprazole Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Omeprazole Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Product Picture of Injection
Figure 12. Global Omeprazole Sales Market Share by Type in 2020
Figure 13. Global Omeprazole Revenue Market Share by Type (2016-2021)
Figure 14. Omeprazole Consumed in Children
Figure 15. Global Omeprazole Market: Children (2016-2021) & (K MT)
Figure 16. Omeprazole Consumed in Adult
Figure 17. Global Omeprazole Market: Adult (2016-2021) & (K MT)
Figure 18. Global Omeprazole Sales Market Share by Application (2016-2021)
Figure 19. Global Omeprazole Revenue Market Share by Application in 2020
Figure 20. Global Omeprazole Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Omeprazole Revenue Market Share by Company in 2020
Figure 22. Global Omeprazole Sales Market Share by Regions (2016-2021)
Figure 23. Global Omeprazole Revenue Market Share by Region in 2020
Figure 24. Americas Omeprazole Sales 2016-2021 (K MT)
Figure 25. Americas Omeprazole Revenue 2016-2021 ($ Millions)
Figure 26. APAC Omeprazole Sales 2016-2021 (K MT)
Figure 27. APAC Omeprazole Revenue 2016-2021 ($ Millions)
Figure 28. Europe Omeprazole Sales 2016-2021 (K MT)
Figure 29. Europe Omeprazole Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Omeprazole Sales 2016-2021 (K MT)
Figure 31. Middle East & Africa Omeprazole Revenue 2016-2021 ($ Millions)
Figure 32. Americas Omeprazole Sales Market Share by Country in 2020
Figure 33. Americas Omeprazole Revenue Market Share by Country in 2020
Figure 34. Americas Omeprazole Sales Market Share by Type in 2020
Figure 35. Americas Omeprazole Sales Market Share by Application in 2020
Figure 36. United States Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Omeprazole Sales Market Share by Region in 2020
Figure 41. APAC Omeprazole Revenue Market Share by Regions in 2020
Figure 42. APAC Omeprazole Sales Market Share by Type in 2020
Figure 43. APAC Omeprazole Sales Market Share by Application in 2020
Figure 44. China Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Omeprazole Sales Market Share by Country in 2020
Figure 51. Europe Omeprazole Revenue Market Share by Country in 2020
Figure 52. Europe Omeprazole Sales Market Share by Type in 2020
Figure 53. Europe Omeprazole Sales Market Share by Application in 2020
Figure 54. Germany Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Omeprazole Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Omeprazole Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Omeprazole Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Omeprazole Sales Market Share by Application in 2020
Figure 63. Egypt Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Omeprazole Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


★調査レポート[世界のオメプラゾール市場予測 2021年-2026年] (コード:LPI21MY9607)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオメプラゾール市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆